An assessment of polymorphonuclear leukocyte rigidity in hiv-infected individuals after immune recovery

Investigative Ophthalmology and Visual Science

Volumn 43, Issue 6, 2002, Pages 1857-1861

  Goldenberg, David T ^a   Holland, Gary N ^a   Cumberland, William G ^a   Fisher, Timothy C ^a   Folz, Ina Caren ^a   Wang, Robert C ^a   Terry, Brian G ^a   Moe, Ardis A ^a   Kramer, Françoise ^a   Lim, Jennifer I ^a   Rao, Narsing A ^a   Meiselman, Herbert J ^a  

^a JULES STEIN EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; BLOOD FLOW; BLOOD VESSEL INJURY; CAPILLARY; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; DISEASE SEVERITY; DRUG POTENCY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNE DEFICIENCY; LYMPHOCYTE COUNT; MICROPORE FILTER; MODEL; NEUTROPHIL; PRIORITY JOURNAL; RETINA BLOOD VESSEL; RIGIDITY; T LYMPHOCYTE;

ADULT; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HIV INFECTIONS; HUMANS; IMMUNOSUPPRESSION; MALE; MIDDLE AGED; NEUTROPHILS; RECOVERY OF FUNCTION;

EID: 0036272881     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Hemorheologic abnormalities in patients with human immunodeficiency virus infection and ophthalmic microvasculopathy
2. Decreased macular leukocyte velocity in HIV-infected individuals
3. Role of HIV and CMV in the pathogenesis of retinitis and retinal vasculopathy in AIDS patients
4. Retinal blood flow indices in patients infected with human immunodeficiency virus
5. Elevation of organ resistance due to leukocyte perfusion
6. Increased polymorphonuclear leukocyte rigidity in HIV-infected individuals
7. Ocular manifestations of HIV infection
8. Kinetics of granulocyte deformability following exposure to chemotactic stimuli
9. Cytomegalovirus diseases
10. Acquired immune deficiency syndrome: Pathogenic mechanisms of ocular disease
11. Passive mechanical properties of human leukocytes
12. Rheology of leukocytes
13. Morphometry of human leukocytes
14. Pathogenetic potential of leukocytes in diabetic retinopathy
15. Dependence of adhesive behavior of neutrophils on local fluid dynamics in a region with recirculating flow
16. Polymorphonuclear neutrophils from human immunodeficiency virus-infected patients show enhanced activation, diminished fMLP-induced L-selectin shedding, and an impaired oxidative burst after cytokine priming
17. Differential effects of interleukin-15 (IL-15) and IL-2 on human neutrophils: Modulation of phagocytosis, cytoskeleton rearrangement, gene expression, and apoptosis by IL-15
18. Interleukin-15 enhances neutrophil functional activity in patients with human immunodeficiency virus infection
19. Interleukin-15 activates proinflammatory and antimicrobial functions in polymorphonuclear cells
20. Interleukin-15 (IL-15) induces NF-kappaB activation and IL-8 production in human neutrophils
21. Role of IL-15 in HIV-1-associated hypergammaglobulinaemia
22. Effect of cytokines and colony-stimulating factors on passive polymorphonuclear leukocyte deformability in vitro
23. Altered production of PGE2, IL-1 beta and TNF-alpha by peripheral blood monocytes from HIV-positive individuals at early stages of HIV infection
24. Tumor necrosis factor (TNF) system levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy: Persistent TNF activation is associated with virologic and immunologic treatment failure
25. The effect of long-term treatment with granulocyte colony-stimulating factor on hematopoiesis in HIV-infected individuals
26. Granulocyte colony-stimulating factor increases CD4+ T cell counts of human immunodeficiency virus-infected patients receiving stable, highly active antiretroviral therapy: Results from a randomized, placebo-controlled trial
27. Induction of HIV-1-specific T cell responses by administration of cytokines in late-stage patients receiving highly active anti-retroviral therapy
28. Decrease of cytomegalovirus replication in human immunodeficiency virus infected-patients after treatment with highly active antiretrovival therapy
29. Tissue destruction by neutrophils
30. Visual dysfunction without retinitis in patients with acquired immunodeficiency syndrome
31. Deficits in perimetric performance in patients with symptomatic human immunodeficiency virus infection or acquired immunodeficiency syndrome
32. HIV-related ocular microangiopathic syndrome and color contrast sensitivity
33. Impairment of colour contrast sensitivity and neuroretinal dysfunction in patients with symptomatic HIV infection or AIDS
34. Contrast sensitivity in individuals with AIDS: Severely immunosuppressed individuals versus individuals with immune reconstitution
35. Decreased polymorphonuclear leukocyte deformability in NIDDM
36. Impaired retinal artery blood flow in IDDM patients before clinical manifestations of diabetic retinopathy
37. Contrast sensitivity loss is coupled with capillary dropout in patients with diabetes